UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): August 16, 2012
CardioNet, Inc.
(Exact name of registrant as specified in its charter)
Delaware |
|
001-33993 |
|
33-0604557 |
(State or other jurisdiction |
|
(Commission |
|
(I.R.S. Employer |
of incorporation) |
|
File Number) |
|
Identification No.) |
227 Washington Street #210 Conshohocken, PA |
|
19428 |
(Address of principal executive offices) |
|
(Zip Code) |
Registrants telephone number, including area code: (610) 729-7000
Not Applicable
Former name or former address, if changed since last report
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 7.01 Regulation FD Disclosure.
On August 16, 2012, the Company announced that its CEO, Joseph Capper adopted a 10b5-1 trading plan. A press release describing this plan is furnished herewith as Exhibit 99.1.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit Number |
|
Exhibit Title |
99.1 |
|
Press Release by the Company, dated August 16, 2012 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
CardioNet, Inc. | ||
|
| ||
|
| ||
August 17, 2012 |
By: |
/s/ Peter Ferola | |
|
|
| |
|
|
Name: |
Peter Ferola |
|
|
Title: |
Senior Vice President and General Counsel |